Journal of Natural Medicines

, Volume 71, Issue 4, pp 685–692 | Cite as

Comparison of the ameliorative effects of Qingfei Tongluo formula and azithromycin on Mycoplasma pneumoniae pneumonia

  • Zhen Xiao
  • Yonghong Jiang
  • Xuan Gao
  • Shuzhu Lin
  • Yan Lin
  • Xiuxiu Liu
  • Dan Tan
  • Zhiyan Jiang
Original Paper


Mycoplasma pneumoniae pneumonia (MPP) is a common disease in children. Qingfei Tongluo formula (QTF) has been used for the treatment of MPP clinically, but the therapeutic effect remains unclear compared to conventional treatments with Western medicines. Therefore, the aim of this study was to assess changes in the expression levels of relevant factors associated with microcirculation after MPP and to compare the therapeutic effect of QTF with that of azithromycin (AZM) on experimental mice with MPP. A total of 174 children admitted with clinical diagnoses of pneumonia (80 MPP and 94 non-MPP) were used to identify differences in the expression patterns of factors in the microcirculation using an enzyme-linked immunosorbent assay. A BALB/c mouse model of MPP infection was established to determine the therapeutic effect of QTF. The results showed that the expression level of thrombomodulin (TM), vascular endothelial growth factor (VEGF), d-dimer (D-D), interleukin (IL)-6, and IL-10 were upregulated after MPP both clinically in children and in the mouse model. After 3 days of therapy, the amount of total MPP DNA decreased, especially in the mid- and high-dose QTF treatment groups. The expression levels of VEGF, IL-6, and IL-10 also decreased in response to treatment with QTF or AZM. However, there was no influence on D-D levels. QTF treatment also decreased TM expression. In conclusion, QTF treatment inhibited the progression of MPP, reduced vascular permeability, and improved pulmonary microcirculation more effectively than conventional treatment with Western medicine.


Mycoplasma pneumoniae Qingfei Tongluo formula Azithromycin Microcirculation 



This work was supported by National Natural Science Foundation of China Project (No. 81574021, 81674024) and Shanghai doctoral construction funds (No. B201402).


  1. 1.
    Chiang WC, Teoh OH, Chong CY, Goh A, Tang JP, Chay OM (2007) Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology 12(2):254–261CrossRefPubMedGoogle Scholar
  2. 2.
    Mathew JL, Singhi S, Ray P, Hagel E, Saghafian-Hedengren S, Bansal A, Ygberg S, Sodhi KS, Kumar BV, Nilsson A (2015) Etiology of community acquired pneumonia among children in India: prospective, cohort study. J Glob Health 5(2):050418CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH Jr (2004) Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113(4):701–707CrossRefPubMedGoogle Scholar
  4. 4.
    Grassi T, Mancini F, Ciervo A, Vescio MF, Ghazal A, Ashour H, Saleh E, El Zalabani M, Donatelli I, El Sawaf G, Rezza G (2014) Chlamydophila pneumoniae, Mycoplasma pneumoniae, and influenza in children with respiratory infections in Alexandria, Egypt. J Infect Dev Ctries 8(3):379–383CrossRefPubMedGoogle Scholar
  5. 5.
    Huong Ple T, Hien PT, Lan NT, Binh TQ, Tuan DM, Anh DD (2014) First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1–15 years. BMC Public Health 14:1304CrossRefPubMedGoogle Scholar
  6. 6.
    Shangguan Z, Sun Q, Zhang M, Ding J, Yi L, Gao Y, Zhan A, Zhao R, Ci X (2014) Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China. J Infect Dev Ctries 8(10):1259–1266CrossRefPubMedGoogle Scholar
  7. 7.
    Balish MF (2014) Mycoplasma pneumoniae, an underutilized model for bacterial cell biology. J Bacteriol 196(21):3675–3682CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jiang YH, Yu JE, Guo AH, Li X, Lin Y, Jiang ZY, Xiao Z (2016) Ameliorative effects of Qingfei Tongluo formula on experimental Mycoplasmal pneumonia in mice. J Nat Med 70(2):145–151CrossRefPubMedGoogle Scholar
  9. 9.
    Guo L, Liu F, Lu MP, Zheng Q, Chen ZM (2015) Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia. Pediatr Pulmonol 50(8):814–819CrossRefPubMedGoogle Scholar
  10. 10.
    Darveaux JI, Lemanske RF Jr (2014) Infection-related asthma. J Allergy Clin Immunol Pract 2(6):658–663CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hong SJ (2012) The Role of Mycoplasma pneumoniae Infection in Asthma. Allergy Asthma Immunol Res 4(2):59–61CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Jeong YC, Yeo MS, Kim JH, Lee HB, Oh JW (2012) Mycoplasma pneumoniae infection affects the serum levels of vascular endothelial growth factor and interleukin-5 in atopic children. Allergy Asthma Immunol Res 4(2):92–97CrossRefPubMedGoogle Scholar
  13. 13.
    Chu HW, Rino JG, Wexler RB, Campbell K, Harbeck RJ, Martin RJ (2005) Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol 289(1):L125–L133CrossRefPubMedGoogle Scholar
  14. 14.
    Boddeke EW (2001) Involvement of chemokines in pain. Eur J Pharmacol 429(1–3):115–119 (Review) CrossRefPubMedGoogle Scholar
  15. 15.
    Bordon J, Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, Peyrani P, Morlacchi LC, Blasi F, Ramirez JA (2013) Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 17(2):e76–e83CrossRefPubMedGoogle Scholar
  16. 16.
    Bordon JM, Uriarte S, Arnold FW, Fernandez-Botran R, Rane M, Peyrani P, Cavallazzi R, Saad M, Ramirez J (2013) Cytokines and neutrophils responses in influenza pneumonia. Infection 41(5):1021–1024CrossRefPubMedGoogle Scholar
  17. 17.
    Gao XJ, Guo MY, Zhang ZC, Wang TC, Cao YG, Zhang NS (2015) Bergenin plays an anti-inflammatory role via the modulation of MAPK and NF-κB signaling pathways in a mouse model of LPS-induced mastitis. Inflammation 38(3):1142–1150CrossRefPubMedGoogle Scholar
  18. 18.
    Wang CP, Zhang LZ, Li GC, Shi YW, Li JL, Zhang XC, Wang ZW, Ding F, Liang XM (2014) Mulberroside A protects against ischemic impairment in primary culture of rat cortical neurons after oxygen-glucose deprivation followed by reperfusion. J Neurosci Res 92(7):944–954CrossRefPubMedGoogle Scholar
  19. 19.
    Hwang HJ, Lee HJ, Kim CJ, Shim I, Hahm DH (2008) Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis. J Microbiol Biotechnol 18(10):1641–1647PubMedGoogle Scholar
  20. 20.
    Ikeda Y, Murakami A, Ohigashi H (2008) Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 52(1):26–42CrossRefPubMedGoogle Scholar
  21. 21.
    Hoshino M, Takahashi M, Aoike N (2001) Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107(2):295–301CrossRefPubMedGoogle Scholar
  22. 22.
    Hoshino M, Nakamura Y, Hamid QA (2001) Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107(6):1034–1038CrossRefPubMedGoogle Scholar
  23. 23.
    McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE (2000) Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 161:1877–1880CrossRefPubMedGoogle Scholar
  24. 24.
    McDonald DM (2001) Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:39–45CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Pharmacognosy and Springer Japan KK 2017

Authors and Affiliations

  1. 1.Department of Pediatric, Longhua HospitalShanghai University of TCMShanghaiChina

Personalised recommendations